Literature DB >> 22328154

Extracting β-amyloid from Alzheimer's disease.

Daniel R Dries1, Gang Yu, Joachim Herz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22328154      PMCID： PMC3295249          DOI： 10.1073/pnas.1121560109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  19 in total

1.  Withania somnifera reverses Alzheimer's disease pathology by enhancing low-density lipoprotein receptor-related protein in liver.

Authors:  Neha Sehgal; Alok Gupta; Rupanagudi Khader Valli; Shanker Datt Joshi; Jessica T Mills; Edith Hamel; Pankaj Khanna; Subhash Chand Jain; Suman S Thakur; Vijayalakshmi Ravindranath
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

Review 2.  Clearance of amyloid-beta in Alzheimer's disease: progress, problems and perspectives.

Authors:  Yan-Jiang Wang; Hua-Dong Zhou; Xin-Fu Zhou
Journal:  Drug Discov Today       Date:  2006-09-07       Impact factor: 7.851

3.  Neuritic regeneration and synaptic reconstruction induced by withanolide A.

Authors:  Tomoharu Kuboyama; Chihiro Tohda; Katsuko Komatsu
Journal:  Br J Pharmacol       Date:  2005-04       Impact factor: 8.739

4.  Resolving controversies on the path to Alzheimer's therapeutics.

Authors:  Dennis J Selkoe
Journal:  Nat Med       Date:  2011-09-07       Impact factor: 53.440

Review 5.  Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease.

Authors:  R Deane; R D Bell; A Sagare; B V Zlokovic
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-03       Impact factor: 4.388

Review 6.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

7.  Withanoside IV and its active metabolite, sominone, attenuate Abeta(25-35)-induced neurodegeneration.

Authors:  Tomoharu Kuboyama; Chihiro Tohda; Katsuko Komatsu
Journal:  Eur J Neurosci       Date:  2006-03       Impact factor: 3.386

Review 8.  Amyloid-beta fibrillogenesis: structural insight and therapeutic intervention.

Authors:  Kevin A Dasilva; James E Shaw; Joanne McLaurin
Journal:  Exp Neurol       Date:  2009-09-08       Impact factor: 5.330

Review 9.  Amyloid-degrading enzymes as therapeutic targets in Alzheimer's disease.

Authors:  Natalia N Nalivaeva; Lilia R Fisk; Nikolai D Belyaev; Anthony J Turner
Journal:  Curr Alzheimer Res       Date:  2008-04       Impact factor: 3.498

10.  Prevention of Alzheimer's disease in high risk groups: statin therapy in subjects with PSEN1 mutations or heterozygosity for apolipoprotein E epsilon 4.

Authors:  Daniel A Pollen; Stephen Baker; Douglas Hinerfeld; Joan Swearer; Barbara A Evans; James E Evans; Richard Caselli; Ekaterina Rogaeva; Peter St George-Hyslop; Majaz Moonis
Journal:  Alzheimers Res Ther       Date:  2010-10-29       Impact factor: 6.982
View more
  8 in total

1.  PPAR Gamma Coactivator 1 Beta (PGC-1β) Reduces Mammalian Target of Rapamycin (mTOR) Expression via a SIRT1-Dependent Mechanism in Neurons.

Authors:  Ying-Chun Liu; Xiao-Xiao Gao; Zhi-Guang Zhang; Zhao-Hua Lin; Qi-Lian Zou
Journal:  Cell Mol Neurobiol       Date:  2016-09-15       Impact factor: 5.046

Review 2.  Low-density lipoprotein receptor-related protein 1: a physiological Aβ homeostatic mechanism with multiple therapeutic opportunities.

Authors:  Abhay P Sagare; Rashid Deane; Berislav V Zlokovic
Journal:  Pharmacol Ther       Date:  2012-07-20       Impact factor: 12.310

3.  Astrocytic LRP1 Mediates Brain Aβ Clearance and Impacts Amyloid Deposition.

Authors:  Chia-Chen Liu; Jin Hu; Na Zhao; Jian Wang; Na Wang; John R Cirrito; Takahisa Kanekiyo; David M Holtzman; Guojun Bu
Journal:  J Neurosci       Date:  2017-03-08       Impact factor: 6.167

Review 4.  Neurovascular defects and faulty amyloid-β vascular clearance in Alzheimer's disease.

Authors:  Abhay P Sagare; Robert D Bell; Berislav V Zlokovic
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

5.  Inflammatory Cytokine IL-1β Downregulates Endothelial LRP1 via MicroRNA-mediated Gene Silencing.

Authors:  Heng-Wei Hsu; Carlos J Rodriguez-Ortiz; Joannee Zumkehr; Masashi Kitazawa
Journal:  Neuroscience       Date:  2020-11-24       Impact factor: 3.590

6.  The role of the blood-brain barrier in the pathogenesis of senile plaques in Alzheimer's disease.

Authors:  J Provias; B Jeynes
Journal:  Int J Alzheimers Dis       Date:  2014-09-18

7.  Notch1 hallmarks fibrillary depositions in sporadic Alzheimer's disease.

Authors:  Emanuele Brai; Noemi Alina Raio; Lavinia Alberi
Journal:  Acta Neuropathol Commun       Date:  2016-07-01       Impact factor: 7.801

8.  High-Fat Diet Modulates Hepatic Amyloid β and Cerebrosterol Metabolism in the Triple Transgenic Mouse Model of Alzheimer's Disease.

Authors:  Cristina R Bosoi; Milène Vandal; Marine Tournissac; Manon Leclerc; Hortense Fanet; Patricia L Mitchell; Mélanie Verreault; Jocelyn Trottier; Jessica Virgili; Cynthia Tremblay; H Robert Lippman; Jasmohan S Bajaj; Olivier Barbier; André Marette; Frédéric Calon
Journal:  Hepatol Commun       Date:  2020-12-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.